Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CLOV - IPOF Stock Keeps Heating Up as SpaceX SPAC Merger Rumors Persist


CLOV - IPOF Stock Keeps Heating Up as SpaceX SPAC Merger Rumors Persist

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Who will Social Capital Hedosophia VI (NYSE:IPOF) merge with? Currently, there are a multitude of speculations to answer this question. On Stocktwits, message volume for the IPOF ticker has increased by 19%. Furthermore, several Stocktwits members are circulating rumors that Chamath Palihapitiya’s special purpose acquisition company (SPAC) may merge with SpaceX, although the validity of this claim is purely based on speculation. Last year, Palihapitiya helped take several companies public via SPAC, such as Clover Health (NASDAQ:CLOV) and Virgin Galactic (NYSE:SPCE).

Source: L Galbraith / Shutterstock.com

Will IPOF Stock Merge With SpaceX?

A SpaceX merger with IPOF stock would send shockwaves through the markets. What’s more, chatter on social media is factoring in Palihapitiya’s interest in space travel because of the Virgin Galactic SPAC merger. Adding more fuel to the flame is Palihapitiya’s announcement that he would be stepping down from the board of Virgin Galactic. As a result, investors are speculating that he stepped down to pursue a SpaceX merger.

However, this is highly unlikely. Knowing Elon Musk, it’s likely that he would favor an initial public offering (IPO) or direct listing. In addition, SpaceX has also raised more than $7.5 billion in funding rounds with investors that include the United States Space Force and Spectre. Until we hear confirmation from either side, the SpaceX speculation is most likely, well, just speculation.

Who’s Betting Big on IPOF?

According to WhaleWisdom, institutional investors own 67 million shares of IPOF stock, which was an increase of 12% compared to the previous quarter. As of Q4, a total of 121 funds owned the SPAC in their portfolios, which was a quarter-over-quarter increase of 2.5%. Here are the top five shareholders of IPOF common stock:

  1. Cowen and Company: 6.5 million shares or 5.6% ownership. During Q4, the fund purchased 6.3 million shares. Additionally, IPOF is Cowen’s largest position.
  2. Millennium Management: 4.2 million shares or 3.7% ownership. During Q4, the fund sold 367,822 shares.
  3. Fort Baker Capital Management: 3.3 million shares or 2.9% ownership. During Q4, the fund purchased 2 million shares.
  4. Empyrean Capital Partners: 3.2 million shares or 2.7% ownership. During Q4, the fund kept its position unchanged.
  5. Linden Advisors: 3.01 million shares or 2.6% ownership. During Q4, the fund purchased 373,000 shares.

On the date of publication, Eddie Pan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

More From InvestorPlace

The post IPOF Stock Keeps Heating Up as SpaceX SPAC Merger Rumors Persist appeared first on InvestorPlace.

Stock Information

Company Name: Clover Health Investments Corp.
Stock Symbol: CLOV
Market: NYSE
Website: cloverhealth.com

Menu

CLOV CLOV Quote CLOV Short CLOV News CLOV Articles CLOV Message Board
Get CLOV Alerts

News, Short Squeeze, Breakout and More Instantly...